[Peracetic acid as disinfectant--a review].

H. Flemming

1984-05-01

Abstract:

What problem does this paper attempt to address?

Improved systolic and diastolic myocardial function with intracoronary pyruvate in patients with congestive heart failure

H. Hermann,Jordis Arp,B. Pieske,H. Kögler,Steffen Baron,Paul M.L. Janssen,G. Hasenfuss

DOI: https://doi.org/10.1016/j.ejheart.2003.10.001

2003-12-13

European Journal of Heart Failure

Abstract:
Early continuous ultrafiltration in Chinese patients with congestive heart failure (EUC-CHF): study protocol for an open-label registry-based prospective clinical trial.

Ying Yang,Chao Shen,Jiangting Lu,Fen Xu,Jinshan Tong,Jiangfen Jiang,Guosheng Fu

DOI: https://doi.org/10.1186/s12872-019-1208-y

IF: 2.174

2019-01-01

BMC Cardiovascular Disorders

Abstract:BACKGROUND:Conventional pharmacologic therapies aim to reduce fluid overload in advanced heart failure (HF) represented by intravenous (IV) loop diuretics (LDs) have sometimes not so efficacious and been reported to have side effects such as unpredictable removal of water and sodium and electrolyte disturbance. It is not certain whether early ultrafiltration (UF) is effective than LDs in relieving edema. Given the weakness of evidence for early UF in patients with fluid overload, recommendations of UF in guidelines is considered as second-line therapy only for patients with refractory congestion, who failed to respond to LD-based strategies. METHODS:The early continuous ultrafiltration in Chinese patients with congestive heart failure (EUC-CHF) trial is an open-label, registry-based, prospective study, recruiting patients with severe acute decompensated HF who are hospitalized for HF worsening due to overt fluid overload 24 h from hospital admission. Forty patients will be enrolled to two treatment groups (n = 20 for each group). The primary outcomes are the changes of weight loss and dyspnea severity score after treatment, as well as the occurrence of clinically overt major bleeding. DISCUSSION:EUC-CHF trial was primarily designed to evaluate the efficacy and safety of early UF in patients with acute decompensated HF to reduce volume overload and improve clinical outcome. The trial aims to determine if early UF in acute HF is superior to IV LDs in clinical parameter improvement without adverse events and prevents rehospitalization up to 30 days. Also the trial is expected to establish a scoring system based on Chinese population to guide early UF treatment in appropriate patients. EUC-CHF is one of the first controlled trials tailored to determine the benefit of UF with 24 h from hospital admission. TRIAL REGISTRATION:www.chictr.org.cn, ChiCTR1800019556. Registered on 18 November 2018.
The prognostic value of improving congestion on lung ultrasound during treatment for acute heart failure differs based on patient characteristics at admission

Nicholas E Harrison,Robert Ehrman,Sean Collins,Ankit A Desai,Nicole M Duggan,Rob Ferre,Luna Gargani,Andrew Goldsmith,Tina Kapur,Katie Lane,Phillip Levy,Xiaochun Li,Vicki E Noble,Frances M Russell,Peter Pang

DOI: https://doi.org/10.1016/j.jjcc.2023.08.003

Abstract:Background: Lung ultrasound congestion scoring (LUS-CS) is a congestion severity biomarker. The BLUSHED-AHF trial demonstrated feasibility for LUS-CS-guided therapy in acute heart failure (AHF). We investigated two questions: 1) does change (∆) in LUS-CS from emergency department (ED) to hospital-discharge predict patient outcomes, and 2) is the relationship between in-hospital decongestion and adverse events moderated by baseline risk-factors at admission? Methods: We performed a secondary analysis of 933 observations/128 patients from 5 hospitals in the BLUSHED-AHF trial receiving daily LUS. ∆LUS-CS from ED arrival to inpatient discharge (scale -160 to +160, where negative = improving congestion) was compared to a primary outcome of 30-day death/AHF-rehospitalization. Cox regression was used to adjust for mortality risk at admission [Get-With-The-Guidelines HF risk score (GWTG-RS)] and the discharge LUS-CS. An interaction between ∆LUS-CS and GWTG-RS was included, under the hypothesis that the association between decongestion intensity (by ∆LUS-CS) and adverse outcomes would be stronger in admitted patients with low-mortality risk but high baseline congestion. Results: Median age was 65 years, GWTG-RS 36, left ventricular ejection fraction 36 %, and ∆LUS-CS -20. In the multivariable analysis ∆LUS-CS was associated with event-free survival (HR = 0.61; 95 % CI: 0.38-0.97), while discharge LUS-CS (HR = 1.00; 95%CI: 0.54-1.84) did not add incremental prognostic value to ∆LUS-CS alone. As GWTG-RS rose, benefits of LUS-CS reduction attenuated (interaction p < 0.05). ∆LUS-CS and event-free survival were most strongly correlated in patients without tachycardia, tachypnea, hypotension, hyponatremia, uremia, advanced age, or history of myocardial infarction at ED/baseline, and those with low daily loop diuretic requirements. Conclusions: Reduction in ∆LUS-CS during AHF treatment was most associated with improved readmission-free survival in heavily congested patients with otherwise reassuring features at admission. ∆LUS-CS may be most useful as a measure to ensure adequate decongestion prior to discharge, to prevent early readmission, rather than modify survival.
Inferior vena CAVA and lung ultraSound-guided therapy in acute heart failure: A randomized pilot study (CAVAL US-AHF study)

Lucrecia María Burgos,Rocio Consuelo Baro Vila,Franco Nicolás Ballari,Ailin Goyeneche,Juan Pablo Costabel,Florencia Muñoz,Ana Spaccavento,Martín Andrés Fasan,Lucas Leonardo Suárez,Martin Vivas,Laura Riznyk,Sebastian Ghibaudo,Marcelo Trivi,Ricardo Ronderos,Fernando Botto,Mirta Diez,CAVAL US—AHF group

DOI: https://doi.org/10.1016/j.ahj.2024.07.015

Abstract:Background: The optimal assessment of systemic and lung decongestion during acute heart failure is not clearly defined. We evaluated whether inferior vena cava (IVC) and pulmonary ultrasound (CAVAL US) guided therapy is superior to standard care in reducing subclinical congestion at discharge in patients with AHF. Methods: CAVAL US-AHF was an investigator-initiated, single-center, single-blind, randomized controlled trial. A daily quantitative ultrasound protocol using the 8-zone method was used and treatment was adjusted according to an algorithm. The primary endpoint was the presence of more than 5 B-lines and/or an increase in IVC diameter and collapsibility at discharge. And secondary endpoint exploratory outcome was the composite of readmission for HF, unplanned visit for worsening HF or death at 90 days RESULTS: Sixty patients were randomized to CAVAL US (n = 30) or control (n = 30). The primary endpoint was achieved in 4 patients (13.3%) in the CAVAL US group and 20 patients (66.6%) in the control group (P < .001). A significant reduction in HF readmission, unplanned visit for worsening HF or death at 90 days was seen in the CAVAL US group (13.3% vs 36.7%; log rank P = .038). Other endpoints such as NT-proBNP reduction at discharge showed a nonstatistically significant reduction in the CAVAL US group (48% IQR 27-67 vs 37% -3-59; P = .09). Safety outcomes were similar in both groups. Conclusion: IVC and lung ultrasound-guided therapy in AHF patients significantly reduced subclinical congestion at discharge. CAVAL US-AHF provides preliminary evidence for the potential use of a simple technique to guide decongestive therapy during hospitalization for AHF, which may reduce the composite outcome at 90 days.
LUDT-ADHF trial: Lung ultrasound-guided diuretic therapy for hospitalized patients with acute decompensated heart failure: An open-label clinical trial

Masoud Kashoob,Salim Al-Busaidi,Juhaina Salim Al-Maqbali,Amira Al-Badi,Aya Aalhamad,Zubaida Al Falahi,Aisha Al Huraizi,Hatem Al Farhan,Khalfan Al Zeedy,Abdul Hakeem Al Hashim,Mohammed H Al-Ghailani,Muhammad Shoaib,Haitham El Bingawi,Abdullah M Al Alawi

DOI: https://doi.org/10.1016/j.hrtlng.2024.10.001

Abstract:Background Acute Decompensated Heart Failure (ADHF) constitutes a major reason for hospital admissions and significantly contributes to increased morbidity and mortality. Limited research indicates that lung ultrasound (LUS) may enhance the care for patients with ADHF. Objectives The purpose of this study was to evaluate the impact of LUS-guided diuretic therapy on reducing length of hospital stay (LOS) and 90-day readmissions among patients with ADHF. Methods This open-label, non-randomized clinical trial included patients with ADHF managed with diuretics based on LUS findings of B-lines and pleural effusion (LUS group) compared to those receiving standard care (control group). The primary outcome was LOS during the index admission, and secondary outcomes included 90-day ADHF readmissions, all-cause readmissions, and safety parameters like acute kidney injury, hypokalemia, and hypotension. Results The study included a total of 77 patients, segregated into two groups: control and LUS. The median age of the patients was 68 years, with women slightly outnumbering men (53.25%, n=41). The most prevalent comorbidities were hypertension (88.31%, n=68), diabetes mellitus (59.74%, n=46), and chronic kidney disease (66.23%, n=51). The LUS group had a shorter LOS, though not statistically significant (4 vs five days, p= 0.175). Patients in the LUS group had significantly fewer 90-day ADHF readmissions compared to the control group (10.53% vs. 35.9%; p<0.01). Survival analysis demonstrated that the LUS group had a longer time to 90-day ADHF readmissions, with a hazard ratio (HR) of 0.24 (95% CI: 0.08-0.75, p=0.014). For 90-day all-cause readmissions, the LUS group also showed a longer time to readmission compared to controls, with an HR of 0.45 (95% CI: 0.200-1.005, p=0.046). For other safety measures, there was no significant difference in the incidence of adverse events, including acute kidney injury, hypokalaemia, or hypotension, between the LUS and control groups. Conclusion LUS might reduce in-hospital mortality and readmissions among adults with acute decompensated HF. However, further double-blinded randomized clinical trials are needed to confirm these preliminary results.
The assessment, interpretation and implementation of lung ultrasound examinations in Heart Failure: Current evidence and gaps in knowledge

Alberto Palazzuoli,Matteo Beltrami,Nicolas Girerd,Anna Maw,Gaetano Ruocco,Elke Platz

DOI: https://doi.org/10.1016/j.ejim.2024.09.013

IF: 7.749

2024-10-20

European Journal of Internal Medicine

Abstract:Lung ultrasound (LUS) is a simple, fast and non-invasive tool for pulmonary congestion assessment with higher accuracy for the detection of acute heart failure (HF) compared to clinical examination and chest radiography. The integrated assessment with other ultrasound and echocardiographic parameters can lead to a better systemic and pulmonary congestion characterization. Additionally, the combination of echocardiographic and pulmonary features can identify patients at higher risk for adverse outcomes, potentially facilitating both acute and chronic HF management and prognostic stratification. However, the optimal utilization of LUS needs to be better defined both in terms of imaging method and B-line thresholds which may differ based on the clinical scenario and, potentially, the HF phenotype. Despite the extensive potential role of LUS in a wide range of HF scenarios, clinicians may be unaware of the correct technique and exam interpretation. Specifically, the interpretation of LUS findings is influenced by several factors, such as imaging protocol, type of ultrasound transducer, patient positioning, and presence of concomitant pulmonary diseases. The aim of this review is to provide a practical overview of LUS in patients with known or suspected HF with the goal of providing a practical guide for clinicians and nurses in various clinical settings.

medicine, general & internal
Diagnostic accuracy of prehospital lung ultrasound for acute decompensated heart failure: A systematic review and meta-analysis

Frances M. Russell,Nicholas E. Harrison,Oliver Hobson,Nicholas Montelauro,Cecelia J. Vetter,Daniel Brenner,Sarah Kennedy,Benton R. Hunter

DOI: https://doi.org/10.1016/j.ajem.2024.03.021

IF: 3.6

2024-03-19

The American Journal of Emergency Medicine

Abstract:Background Lung ultrasound (LUS) reduces time to diagnosis and treatment of acute decompensated heart failure (ADHF) in emergency department (ED) patients with undifferentiated dyspnea. We conducted a systematic review to evaluate the diagnostic accuracy and clinical impact of LUS for ADHF in the prehospital setting. Methods We performed a keyword search of multiple databases from inception through June 1, 2023. Included studies were those enrolling prehospital patients with undifferentiated dyspnea or suspected ADHF, and specifically diagnostic studies comparing prehospital LUS to a gold standard and intervention studies with a non-US comparator group. Title and abstract screening, full text review, risk of bias (ROB) assessments, and data extraction were performed by multiple authors. and adjudicated. The primary outcome was pooled sensitivity, specificity, and diagnostic likelihood ratios (LR) for prehospital LUS. A test-treatment threshold of 0.7 was applied based on prior ADHF literature in the ED. Intervention outcomes included mortality, mechanical ventilation, and time to HF specific treatment. Results Eight diagnostic studies ( n = 691) and two intervention studies ( n = 70) met inclusion criteria. No diagnostic studies were low-ROB. Both intervention studies were critical-ROB, and not pooled. Pooled sensitivity and specificity of prehospital LUS for ADHF were 86.7% (95%CI:70.8%–94.6%) and 87.5% (78.2%–93.2%), respectively, with similar performance by physician vs. paramedic LUS and number of lung zones evaluated. Pooled LR+ and LR- were 7.27 (95% CI: 3.69–13.10) and 0.17 (95% CI: 0.06–0.34), respectively. Area under the summary receiver operating characteristic curve was 0.922. At the observed 42.4% ADHF prevalence (pre-test probability), positive pre-hospital LUS exceeded the 70% threshold to initiate treatment (post-test probability 84%, 80–88%). Conclusions LUS had similar diagnostic test characteristics for ADHF diagnosis in the prehospital setting as in the ED. A positive prehospital LUS may be sufficient to initiate early ADHF treatment based on published test-treatment thresholds. More studies are needed to determine the clinical impact of prehospital LUS.

emergency medicine
SIMPLIFID LUNG ULTRASOUND IN DIAGNOSIS OF HEART FAILURE WITH PRESERVED EJECTION FRACTION IN ARTERIAL HYPERTENSION

Mikheil Tsverava,Dimitri Tsverava

DOI: https://doi.org/10.1097/01.hjh.0001020840.11465.82

IF: 4.9

2024-05-01

Journal of Hypertension

Abstract:Objective: About 30% of patients with heart failure (HF) have normal Ejection Fraction (HFpEF). Pulmonary congestion is useful marker of HFpEF. The aim of this study was to determine the efficacy of ultrasound in patients with DHF. Design and method: We studied 250 patients with Arterial Hypertension and III-IV NYHA class HF from which 70 patients had HFpEF (group 1) and 100 patients Left Ventricular Diastolic Dysfunction but without signs of HF (control, group 2). All participants undergone standard Echo Cardiography. Sonographic evaluation of a lung was done in horizontal or vertical positions of patient, from 10 points of thoracic wall (5 points from each side), which corresponded to the projection of lower, middle and upper lobes of a right lung and upper and lower lobes of left lung. Results: In patients with HFpEF we significantly often found multiple (3 or more) B-lines or Comet tail Phenomenon (CTPh), which was registered in 91.1%. In 40.0% of control group patients, we also registered B-lines, but the count of them was less than 3 lines per each registration point (the difference between control an HF groups was significant). The count of points from where the CTPh was registered was 6.8 in HFpEF gr. and 0.7 in control. The B-lines were registered from 3 or more points of thoracic wall in 82.86% of patients of I gr and only 5% in II gr participants. In HF groups CTPh was prominent and multiple while in the control group it was single and short lasting, like lightening. There was good correlation between the count of B-line registration points from the thoracic wall and the heart failure NYHA class (r=0.56), left ventricular systolic (r=0.40) and diastolic (r=0.32) diameters and negative MAPS and TAPS (r=-0.42 and 0.41 respectively). Conclusions: Thoracic US is a sensitive and accurate method for evaluation pulmonary congestion in patients with AH and HFpEF. The US sign of pulmonary congestion in HF are B-lines or Comet tail phenomenon, which is protracted, prominent, multiple and registered from larger area of thoracic wall (3 points or more).

peripheral vascular disease
Diagnosis and Treatment of Acute Heart Failure: A Retrospective Observational Study and Medical Audit

Justas Suchina,Giorgia Lüthi-Corridori,Fabienne Jaun,Jörg D Leuppi,Maria Boesing

DOI: https://doi.org/10.3390/jcm13195951

2024-10-07

Abstract:Background: Acute Heart Failure (AHF) is a leading cause of hospitalizations and remains a significant socioeconomic burden. Despite advances in medical care, mortality and rehospitalization rates remain high. Previous AHF audits have revealed regional differences and a poor adherence to guidelines. This study aimed to assess guideline adherence in a public teaching hospital to identify areas for improvement. Methods: This retrospective observational study examined clinical routine data of patients hospitalized for AHF at a Swiss public teaching hospital between 2018 and 2019. AHF management was evaluated against the relevant guidelines of the European Society of Cardiology. Results: The study included 760 AHF cases of 726 patients (median age 84 years, range 45-101, 50% female). NT-pro-BNP levels were measured in 92% of the cases. Electrocardiography was performed in 95% and chest X-rays in 90% of cases. Echocardiography was conducted in 54% of all cases and in 63% of newly diagnosed AHF cases. Intravenous furosemide was initiated in 76%. In the subgroup of cases with reduced ejection fraction (HFrEF), 86% were discharged with beta-blockers and 69% with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers. Among cases with left ventricular ejection fraction ≤ 35%, mineralocorticoid receptor antagonists were prescribed in 55%. Conclusions: We observed generally good adherence to guideline recommendations. However, several improvements are needed in initial assessment and documentation, diagnostic procedures such as echocardiography, discharge medication, and lifestyle recommendations. Compared to other studies, our diagnostic workup was more aligned with guidelines, the use of intravenous diuretics was similar, and the duration of hospital stay and mortality rates were comparable.
Multi-modality assessment of congestion in acute heart failure: Associations with left ventricular ejection fraction and prognosis

Alberto Palazzuoli,Gaetano Ruocco,Pierpaolo Pellicori,Luna Gargani,Stefano Coiro,Zohra Lamiral,Giuseppe Ambrosio,Tripti Rastogi,Nicolas Girerd

DOI: https://doi.org/10.1016/j.cpcardiol.2024.102374

IF: 16.464

2024-01-11

Current Problems in Cardiology

Abstract:Background Integrating clinical examination with ultrasound measures of congestion could improve risk stratification in patients hospitalized with acute heart failure (AHF). Aim To investigate the prevalence of clinical, echocardiographic and lung ultrasound (LUS) signs of congestion according to left ventricular ejection fraction (LVEF) and their association with prognosis in patients with AHF. Methods We pooled the data of four cohorts of patients ( N = 601, 74.9±10.8 years, 59 % men) with AHF and analysed six features of congestion at enrolment: clinical (peripheral oedema and respiratory rales), biochemical (BNP/NT-proBNP≥median), echocardiographic (inferior vena cava (IVC)≥21 mm, pulmonary artery systolic pressure (PASP)≥40 mmHg, E/e'≥15) and B-lines ≥25 (8-zones) in those with reduced (<40 %, HFrEF), mildly reduced (40–49 %, HFmrEF and preserved (≥50 %HFpEF) LVEF. Results Compared to patients with HFmrEF ( n = 110) and HFpEF ( n = 201), those with HFrEF ( N = 290) had higher natriuretic peptides, but prevalence of clinical (39 %), echocardiographic (IVC≥21 mm: 56 %, E/e'≥15: 57 %, PASP≥40 mmHg: 76 %) and LUS (48 %) signs of congestion was similar. In multivariable analysis, clinical (HR: 3.24(2.15–4.86), p < 0.001), echocardiographic [(IVC≥21 mm (HR:1.91, 1.21–3.03, p=0.006); E/e'≥15 (HR:1.54, 1.04–2.28, p = 0.031)] and LUS (HR:2.08, 1.34–3.24, p = 0.001) signs of congestion were significantly associated with all-cause mortality and/or HF re-hospitalization. Adding echocardiographic and LUS features of congestion to a model than included age, sex, systolic blood pressure, clinical congestion and natriuretic peptides, improved prediction at 90 and 180 days. Conclusions Clinical and ultrasound signs of congestion are highly prevalent in patients with AHF, regardless of LVEF and their combined assessment improves risk stratification.

cardiac & cardiovascular systems
Use of Imaging-Guided Decongestion for Reducing Heart Failure Readmission and Death in High-risk Patients: A multi-site Randomized Trial of a Nurse-led Strategy at Point-of-Care

Georgios Zisis,Melinda J Carrington,Yang Yang,Quan Huynh,Maria Lay,Kristyn Whitmore,James L. Hare,Ingrid Hopper,Nathan Dwyer,Thomas H Marwick,Yang Yang MD

DOI: https://doi.org/10.1016/j.cardfail.2023.12.007

IF: 6.592

2023-12-27

Journal of Cardiac Failure

Abstract:Background Nurse-led disease management programs (DMPs) reduce readmission after Acute Decompensated Heart Failure (ADHF). We sought whether readmissions could be further reduced by lung ultrasound (LUS)-guided decongestion pre-discharge and during DMP. Methods Of 290 patients hospitalized with ADHF, 122 at high-risk for readmission or mortality were randomized to receive usual care (UC, n=64) or UC plus intervention (DMP-Plus; n=58), comprising LUS-guided management pre-discharge and at-home follow-up. Residual congestion was identified by ≥10 B-lines detected in 8 lung zones. The outcomes included a composite of readmission and/or mortality at 30- and 90-days, and 90-day HF readmission. Results Residual congestion was detected equally among the patient groups. The 30-day composite outcome occurred in 28% DMP-plus patients and 22% UC patients (OR 1.36 [95% CI: 0.59-3.1]; p=0.5) and the 90-day HF readmission outcome occurred in 22% and 31% respectively (OR 0.63 [0.28-1.43]; p=0.3) Residual congestion, identified at pre-discharge LUS in high-risk patients, was associated with early (<14-day) HF readmission (RR 1.19 [1.06-1.32]; p=0.002) and multiple (≥2) readmissions over 90-days of follow-up (RR 1.09 [1.02-1.16]; p=0.001), independent of demographics and comorbidities. Conclusion Readmission in patients with incomplete decongestion pre-discharge occurs within the first 2-weeks. However, our DMP-plus strategy did not improve the primary outcome.

cardiac & cardiovascular systems
Ultrasound guidance for volume management in patients with heart failure

Michael J Bonios,Stamatis Kyrzopoulos,Dimitris Tsiapras,Stamatis N Adamopoulos

DOI: https://doi.org/10.1007/s10741-019-09863-5

Abstract:Congestion is one of the most prominent characteristics of patients presented with decompensated heart failure and it implies unfavorable prognosis for the heart failure patient. Neurohumoral and immuno-inflammatory activation secondary to cardiac dysfunction constitute the pivotal mechanisms driving the heart failure syndrome that results in progressive fluid accumulation. In addition, fluid redistribution between different vascular compartments in human body guided from sympathetic activity constitutes another mechanism for heart failure decompensation. Ultrasound applied in the form of echocardiography provides invaluable data for the assessment of intracardiac filling pressures. The type of renal venous flow can provide the degree of renal congestion and probably insight into the pathophysiology of the decompensation of heart failure. Assessment of lung congestion in the patient with heart failure can be accomplished by lung ultrasonography. Additionally, clinical studies on the role of ultrasound in the management and prognosis of the congested patient are reviewed. Special heart failure population supported with left ventricular assist devices and extracorporeal membrane oxygenation support constitute an area where ultrasound guidance of fluid management has gained important role.
UNLOADING STRATEGIES IN ADVANCED HEART FAILURE: THE ROLE OF POINT–OF–CARE ULTRASOUND

C Del Giudice,A Caputo,D D‘Arienzo,F Delle Femmine,B Liccardo,C Amarelli,C Marra,F Loffredo,A Varricchio,P Golino

DOI: https://doi.org/10.1093/eurheartjsupp/suae036.335

2024-04-01

European Heart Journal Supplements

Abstract:Abstract Patients with advanced heart failure (HF) exhibit repeated episodes of fluid retention (pulmonary and/or systemic congestion) and/or of reduced cardiac output at rest (peripheral hypoperfusion) requiring hospitalization along with diuretics/inotropic infusion. Pulmonary artery catheter (PAC) provides haemodynamic information to guide the therapy, however PAC is invasive and time consuming. Point of care ultrasonography (POCUS) represents a promising diagnostic tool at the bedside, performed by the physician to assess non invasively volume status, cardiac output and monitor decongestive therapy. Recently, abnormal Doppler flow patterns due to increased right atrial pressure have been described in the hepatic, portal, and intrarenal veins. Thus, the recent venous excess ultrasound score (VExUS) has been used to describe fluid status along with the diameter and collapsibility of the inferior vena cava. Furthermore HF patients show high filling pressures, therefore they often require mechanical or medical unloading. In this regard, point of care ultrasound represents a valid tool to monitor non invasively the filling pressures and the responsiveness to those treatments. Here, we illustrate with several clinical cases where VExUS/POCUS were pivotal in clinical management.

cardiac & cardiovascular systems
Physiotherapist-initiated lung ultrasound to improve intensive care management of a deteriorating patient and prevent intubation: a case report

Maja Leech,Bernie Bissett,Marta Kot,George Ntoumenopoulos

DOI: https://doi.org/10.3109/09593985.2014.1003629

2015-01-29

Physiotherapy Theory and Practice

Abstract:BACKGROUND AND PURPOSE: This case report describes the physiotherapy assessments and interventions provided to a 56-year-old male in an Australian intensive care unit. The non-intubated patient suffered from respiratory deterioration, secretion retention, complete opacification of the left hemithorax on chest X-ray (CXR) and widespread coarse crackles on lung auscultation. The addition of lung ultrasound (LUS) facilitated more accurate diagnosis than what was formed on the basis of CXR and lung auscultation resulting in more effective treatment.METHODS: The method used is a case report. Written consent was obtained from the patient for these data to be published.SUMMARY: Secretion retention was initially suspected (based on clinical examination and CXR) and treated with airway clearance techniques, patient positioning and nasopharyngeal suction. Even though this assisted with secretion removal, the patient continued to have a high perceived work of breathing and increasing oxygen requirements. Physiotherapist performed LUS, under supervision, and revealed a large pleural effusion (1500 mL), which was then drained by the medical team.DISCUSSION: The addition of LUS to the critical care physiotherapist's assessment skills may provide clinical benefit. The increased diagnostic accuracy of LUS compared with other routine assessments warrants further investigation.

rehabilitation
Multiparametric assessment of decongestion in patients admitted with acute heart failure: dynamic changes and correlation with natriuresis

L Gargani,T M Santos,M Mazzola,A Lossi,E Michelotti,G Barbieri,R Sicari,L Ghiadoni,R De Caterina

DOI: https://doi.org/10.1093/eurheartj/ehae666.116

IF: 39.3

2024-10-30

European Heart Journal

Abstract:Background Heart Failure (HF) is a major public health problem, expected to increase in the next few decades. The vast majority of acute HF (AHF) episodes are precipitated by congestion with volume overload and/or fluid redistribution. Current Guidelines stress on the importance of relieving congestion before discharge, recommending anyway only daily assessment of signs and symptoms. Lung ultrasound (LUS) B-lines and other ultrasound markers of congestion has emerged as valuable tools to improve diagnostic accuracy and help clinicians in fluid management. Purpose To assess the dynamic changes of B-lines and other markers of congestion and their relationship with the clinical evaluation, chest X-ray (CXR) and natriuretic peptides in patients admitted for AHF. Methods Fifty-eight patients (age 72±11 ys, 35% women) admitted with acute HF were enrolled. Patients underwent clinical evaluation (Clinical Congestion Score, CCS, including rales, pathological S3 heart sound, pedal oedema, jugular vein distension; range 0-4), and CXR (CXR score, including enlargement and loss of definition of hilar structures, peribronchial and perivascular cuffing, cardiomegaly, pleural effusion; range 0-4). An integrated multiorgan ultrasound exam including LUS B-lines, echocardiography, and venous excess ultrasound (VExUS) score was performed at admission (T0), between 24 and 48 hours from T0 (T1), and at discharge (T2). Follow-up data at 30 days were collected. Results Mean CCS was 1.52±0.99 at T0, with a reduction at T1 (0.86±0.66; p<0.01), and at T2 (0.34±0.66; p<0.01). Sixteen percent of patients with a CCS=0 at T0 showed, however, persistent B-lines on LUS (mean B-lines 19±6). The mean number of B-lines was 26±12 at T0 with a reduction at T1 (17±11; p<0.001), and at T2 (13±11; p<0.001). Other echocardiographic non-invasive hemodynamic parameters, such as pulmonary artery systolic pressure (PASP) and E/e' showed a reduction only at T2, but not at T1 (figure). The number of B-lines correlated at all time points with CCS, CXR score, VExUS score, and NT-proBNP values (all p<0.05). We divided patients into two groups: "responders" (with ≥15 reduction of B-lines between T0 and T2) and "non-responders" (with <15 reduction of B-lines between T0 and T2). Responders had higher chlorine and sodium urinary excretion at T1 compared to non-responders. The number of B-lines at all time points was associated to 30-days cardiovascular mortality at univariable analysis. Neither CCS nor CXR score were associated with 30-day events. Conclusions In patients with acute HF, B-lines quantification is related to standard congestion assessment based on clinical evaluation, CXR and NT-proBNP, showing, however, a more dynamic behaviour in the assessment of decongestion. B-lines variations are also related to diuresis and chlorine urinary output, a recognized predictor of diuretic response. Persistent congestion is related to an increased risk of hospitalization and death.

cardiac & cardiovascular systems
[Volume management of intermittent hemofiltration guided by critical care ultrasound in the treatment of acute kidney injury]

Xiaoqiong Cui,Yongming Zou,Wenqing Gao,Huan Liu,Song Wang,Wei Wei,Yuanshen Song,Hao Wu

DOI: https://doi.org/10.3760/cma.j.cn121430-20220809-00733

Abstract:Objective: To investigate the volume management of intermittent veno-venous hemofiltration (IVVH) guided by critical care ultrasound in the treatment of acute kidney injury (AKI) in patients with heart failure (HF). Methods: A total of 216 patients with HF and AKI treated with IVVH in the coronary care unit (CCU) of the Third Central Hospital of Tianjin from April 2019 to June 2022 were selected as the study subjects, the patients were randomly divided into conventional guidance group (107 cases) and ultrasound guidance group (109 cases). According to the recovery of renal function, IVVH was performed 12 hours every day or 12 hours every other day. The conventional guidance group selected the conventional method to formulate IVVH prescription, and the ultrasound guidance group used critical care ultrasound to adjust the treatment parameters of IVVH on the basis of the conventional guidance group. Respiratory variation index (RVI) of inferior vena cava (IVC), right left ventricular end-diastolic transverse area ratio, early diastolic peak mitral flow velocity/mitral annulus velocity peak (E/E'), aortic flow velocity time integral (VTI), cardiac output (CO), bilateral lung ultrasound B-line range, bilateral renal interlobar arteries resistance index (RI) were recorded before and 3, 6, 9 hours after each treatment. The net dehydration rate was adjusted in real time according to the comprehensive results. Urine volume, serum creatinine (SCr), estimated glomerular filtration rate (eGFR), blood B-type brain natriuretic peptide (BNP), β2-microglobulin (β2-MG) and cystatin C (Cys C) levels of patients in both groups were monitored before and 3, 7 and 10 days after initial treatment, and renal function recovery and clinical prognostic indexes of patients in both groups were recorded. Results: The dehydration rate of the ultrasound guidance group was slow at the beginning of IVVH, and gradually increased after 6 hours, and the overall dehydration rate was significantly slower than that of the conventional guidance group. In the ultrasound guidance group using critical care ultrasound, the RVI gradually increased, the right left ventricular end-diastolic area ratio gradually decreased, the E/E' ratio gradually decreased, and the range of B-line of bilateral lungs gradually decreased, RI of bilateral renal interlobar arteries decreased. At 3, 7 and 10 days after the first IVVH, renal function related indexes in both groups were significantly improved compared with before treatment, and the decline rate of β2-MG and Cys C in the ultrasound guidance group was faster than that in the conventional guidance group at early (3 days) [β2-MG (mg/L): 3.69±1.31 vs. 3.99±1.45, Cys C (mg/L): 2.91±0.95 vs. 3.14±0.96, both P < 0.05], urine volume, SCr and eGFR at 7 days were also significantly improved compared with the conventional guidance group [24-hour urine volume (mL): 1 128.23±153.92 vs. 1 015.01±114.18, SCr (μmol/L): 145.86±32.25 vs. 155.64±28.42, eGFR (mL/min): 50.26±11.24 vs. 46.51±10.61, all P < 0.05]. The time of SCr recovery, the time of reaching polyuria, the total time of IVVH treatment, the time of non-invasive mechanical ventilation and the time of living in CCU in the ultrasound guidance group were shorter than those in the conventional guidance group. The incidences of hypotension, long-term RRT, incidence of major cardiovascular adverse event (MACE) and at 28-day mortality were all lower than those in the conventional guidance group. Kaplan-Meier survival curve showed that the 28-day cumulative survival rate in the ultrasound guidance group was significantly lower than that in the conventional guidance group (Log-Rank test: χ2 = 3.903, P = 0.048). Conclusions: The strategy of IVVH guided by critical care ultrasound in the treatment of HF with AKI has unique advantages.
Lung ultrasound, echocardiography and fluid loading for the differential diagnosis of pulmonary hypertension

M D'alto,B Liccardo,M Di Maio,C Del Giudice,E Romeo,P Argiento,F Renon,A Vergara,A Di Vilio,E Bossone,G Rea,A D'andrea,L Gargani,P Golino,R Naeije

DOI: https://doi.org/10.1093/eurheartj/ehad655.1958

IF: 39.3

2023-11-01

European Heart Journal

Abstract:Abstract Background There may be interest in combining echocardiography and lung ultrasound for the differential diagnosis between pulmonary arterial hypertension (PAH) and post-capillary pulmonary hypertension on heart failure with preserved ejection fraction (PH-HFpEF). Methods Patients referred for PH underwent a right heart catheterization, echocardiography and lung ultrasound before and after rapid infusion of 7 ml/kg of saline. A 7-points echocardiographic score based on cardiac chamber dimensions and estimates of filling pressures was implemented for the prediction of pre-capillary PH. Pulmonary congestion was identified by lung ultrasound B-lines. Results The study enrolled 70 patients with PAH and 77 patients with HFpEF. The PAH patients had a higher echocardiographic score (3.5±1.8 v 1.6±1.5, p <0.001). Figure 1 represents the typical baseline echocardiographic components of pre-capillary pulmonary hypertension prediction score and pre- and post-fluid loading lung ultrasound imaging from patients with PAH and HFpEF respectively. The HFpEF patients had more B-lines both before (8.1±4.2 vs 5.1±3.0; p <0.001) and after fluid loading (14.6±5.4 vs 7.6±3.5; p <0.001), and a more important increase (Δ) of B-lines after fluid loading (6.5±2.9 vs 2.5±1.6; p <0.001). The sensitivity and specificity of the echocardiographic score alone for PAH were 0.91 and 0.49 respectively [area under the curve (AUC) 0.78]. The AUC for PAH was improved by addition of smaller ΔB-lines to the echocardiography prediction score after fluid loading, with significant increase in sensitivity [0.94 (95% CI 0.89;1.00)] and specificity [0.91 (95% CI 0.84;0.97)] and a positive predictive value of 0.90 (CI 0.84;0.97) and a negative predictive value of 0.95 (CI 0.89;1.00). Figure 2 represents the bar plot of AUC for echocardiographic score, pre- fluid loading B-lines, delta E/e', delta B-lines, post- fluid loading E/e', post- fluid loading B-lines, in ascending order. Conclusion Lung ultrasound combined with echocardiography at baseline and after fluid loading has an incremental value for the differential diagnosis between PAH and PH-HFpEF.Figure 1Figure 2

cardiac & cardiovascular systems
A machine learning-based lung ultrasound algorithm for the diagnosis of acute heart failure

Stefano Coiro,Claire Lacomblez,Kevin Duarte,Luna Gargani,Tripti Rastogi,Tahar Chouihed,Nicolas Girerd

DOI: https://doi.org/10.1007/s11739-024-03627-2

2024-05-24

Internal and Emergency Medicine

Abstract:Lung ultrasound (LUS) is an effective tool for diagnosing acute heart failure (AHF). However, several imaging protocols currently exist and how to best use LUS remains undefined. We aimed at developing a lung ultrasound-based model for AHF diagnosis using machine learning. Random forest and decision trees were generated using the LUS data (via an 8-zone scanning protocol) in patients with acute dyspnea admitted to the Emergency Department (PLUME study, N = 117) and subsequently validated in an external dataset (80 controls from the REMI study, 50 cases from the Nancy AHF cohort). Using the random forest model, total B-line sum (i.e., in both hemithoraces) was the most significant variable for identifying AHF, followed by the difference in B-line sum between the superior and inferior lung areas. The decision tree algorithm had a good diagnostic accuracy [area under the curve (AUC) = 0.865] and identified three risk groups (i.e., low 24%, high 70%, and very high-risk 96%) for AHF. The very high-risk group was defined by the presence of 14 or more B-lines in both hemithoraces while the high-risk group was described as having either B-lines mostly localized in superior points or in the right hemithorax. Accuracy in the validation cohort was excellent (AUC = 0.906). Importantly, adding the algorithm on top of a validated clinical score and classical definition of positive LUS scanning for AHF resulted in a significant improvement in diagnostic accuracy (continuous net reclassification improvement = 1.21, P < 0.001). Our simple lung ultrasound-based machine learning algorithm features an excellent performance and may constitute a validated strategy to diagnose AHF.

medicine, general & internal
Thoracentesis to alleviate pleural effusion in acute heart failure: study protocol for the multicentre, open-label, randomised controlled TAP-IT trial

Signe Glargaard,Jakob Hartvig Thomsen,Brian Bridal Løgstrup,Morten Schou,Kasper Karmark Iversen,Christian Tuxen,Olav W Nielsen,Christian Axel Bang,Matias Greve Lindholm,Ekim Seven,Anders Barasa,Nis Stride,Søren Vraa,Marlene Tofterup,Rasmus Vedby Rasmussen,Dan Eik Høfsten,Kasper Rossing,Lars Køber,Finn Gustafsson,Jens Jakob Thune

DOI: https://doi.org/10.1136/bmjopen-2023-078155

IF: 3.006

2024-01-21

BMJ Open

Abstract:Introduction Pleural effusion is present in half of the patients hospitalised with acute heart failure. The condition is treated with diuretics and/or therapeutic thoracentesis for larger effusions. No evidence from randomised trials or guidelines supports thoracentesis to alleviate pleural effusion due to acute heart failure. The Thoracentesis to Alleviate cardiac Pleural effusion Interventional Trial (TAP-IT) will investigate if a strategy of referring patients with acute heart failure and pleural effusion to up-front thoracentesis by pleural pigtail catheter insertion in addition to pharmacological therapy compared with pharmacological therapy alone can increase the number of days the participants are alive and not hospitalised during the 90 days following randomisation. Methods and analysis TAP-IT is a pragmatic, multicentre, open-label, randomised controlled trial aiming to include 126 adult patients with left ventricular ejection fraction ≤45% and a non-negligible pleural effusion due to heart failure. Participants will be randomised 1:1, stratified according to site and anticoagulant treatment, and assigned to referral to up-front ultrasound-guided pleural pigtail catheter thoracentesis in addition to standard pharmacological therapy or to standard pharmacological therapy only. Thoracentesis is performed according to local guidelines and can be performed in participants in the pharmacological treatment arm if their condition deteriorates or if no significant improvement is observed within 5 days. The primary endpoint is how many days participants are alive and not hospitalised within 90 days from randomisation and will be analysed in the intention-to-treat population. Key secondary outcomes include 90-day mortality, complications, readmissions, and quality of life. Ethics and dissemination The study has been approved by the Capital Region of Denmark Scientific Ethical Committee (H-20060817) and Knowledge Center for Data Reviews (P-2021–149). All participants will sign an informed consent form. Enrolment began in August 2021. Regardless of the nature, results will be published in a peer-reviewed medical journal. Trial registration number NCT05017753.

medicine, general & internal
Focused cardiac ultrasound in the early resuscitation of severe sepsis and septic shock: a prospective pilot study

Hiroshi Sekiguchi,Yohei Harada,Hector R. Villarraga,Sunil V. Mankad,Ognjen Gajic

DOI: https://doi.org/10.1007/s00540-017-2312-8

2017-01-31

Journal of Anesthesia

Abstract:PurposePoint-of-care ultrasonography has been increasingly used in the care of critically ill patients; however, reports on its use during active resuscitation are limited. The aim of this study was to investigate the true impact of focused cardiac ultrasound (FCU) during the management of sepsis with early (6-h) resuscitation.MethodsA prospective pilot observational study was conducted at an academic medical center from March 2011 through July 2012. Patients undergoing resuscitation for severe sepsis or septic shock were prospectively enrolled at medical and combined medical–surgical intensive care units. Patients underwent a 10-min FCU examination when echocardiography was not part of their care plan. FCU was performed by sonographers and interpreted by cardiologists to minimize risks of inadequate image acquisition and misinterpretation. Intensivists completed surveys on their diagnostic and therapeutic plans before and after receiving FCU information.ResultsOf the 30 patients enrolled, 18 (60%) were male and the median age was 61 years [interquartile range (IQR) 50–71 years]. Median central venous oxygen saturation and lactate levels were 59.6% (IQR 53.1–66.2%) and 2.7 mmol/L (IQR 1.2–4.1 mmol/L), respectively. Clinical assessment by intensivists before FCU commonly failed to correctly estimate ventricular function; specifically, left ventricular in 12 patients [40%, 95% confidence interval (CI) 25–58%] and right ventricular function in 15 patients (50%, 95% CI 33–67%). Intensivists’ therapeutic plans changed in eight cases (27%, 95% CI 14–44%) after FCU information became available. The most common changes were fluid management and imaging tests. Intensivists’ confidence in their therapeutic plans improved for 11 patients (37%, 95% CI 22–55%).ConclusionFCU is a valuable examination tool during early resuscitation of severe sepsis and septic shock.

anesthesiology

[Peracetic acid as disinfectant--a review].

Improved systolic and diastolic myocardial function with intracoronary pyruvate in patients with congestive heart failure

Early continuous ultrafiltration in Chinese patients with congestive heart failure (EUC-CHF): study protocol for an open-label registry-based prospective clinical trial.

The prognostic value of improving congestion on lung ultrasound during treatment for acute heart failure differs based on patient characteristics at admission

Inferior vena CAVA and lung ultraSound-guided therapy in acute heart failure: A randomized pilot study (CAVAL US-AHF study)

LUDT-ADHF trial: Lung ultrasound-guided diuretic therapy for hospitalized patients with acute decompensated heart failure: An open-label clinical trial

The assessment, interpretation and implementation of lung ultrasound examinations in Heart Failure: Current evidence and gaps in knowledge

Diagnostic accuracy of prehospital lung ultrasound for acute decompensated heart failure: A systematic review and meta-analysis

SIMPLIFID LUNG ULTRASOUND IN DIAGNOSIS OF HEART FAILURE WITH PRESERVED EJECTION FRACTION IN ARTERIAL HYPERTENSION

Diagnosis and Treatment of Acute Heart Failure: A Retrospective Observational Study and Medical Audit

Multi-modality assessment of congestion in acute heart failure: Associations with left ventricular ejection fraction and prognosis

Use of Imaging-Guided Decongestion for Reducing Heart Failure Readmission and Death in High-risk Patients: A multi-site Randomized Trial of a Nurse-led Strategy at Point-of-Care

Ultrasound guidance for volume management in patients with heart failure

UNLOADING STRATEGIES IN ADVANCED HEART FAILURE: THE ROLE OF POINT–OF–CARE ULTRASOUND

Physiotherapist-initiated lung ultrasound to improve intensive care management of a deteriorating patient and prevent intubation: a case report

Multiparametric assessment of decongestion in patients admitted with acute heart failure: dynamic changes and correlation with natriuresis

[Volume management of intermittent hemofiltration guided by critical care ultrasound in the treatment of acute kidney injury]

Lung ultrasound, echocardiography and fluid loading for the differential diagnosis of pulmonary hypertension

A machine learning-based lung ultrasound algorithm for the diagnosis of acute heart failure

Thoracentesis to alleviate pleural effusion in acute heart failure: study protocol for the multicentre, open-label, randomised controlled TAP-IT trial

Focused cardiac ultrasound in the early resuscitation of severe sepsis and septic shock: a prospective pilot study